Innovation is in our DNA. In my opinion it is a process driven by interdisciplinary collaboration and dialogue. However, it only acquires value and significance when it is made useful to people.
Peter Schardt, CTO Siemens Healthineers
Did you know?
Shaping the digital transformation of healthcare
Digital technologies will play an increasingly important role in addressing three of the great challenges in healthcare: improving access and quality of care while minimizing costs.
We’re researching and developing its core technologies:
- Artificial intelligence
- Automation and robotics
We’re currently focusing on innovative solutions for:
Innovating for impact
Innovation only acquires value and significance when it’s made useful for people. More than 70 percent of clinical decisions worldwide are made with our technology1. Our company has the framework to create a product from an invention that can then be mass-produced and eventually be made available to help people around the world.
No matter how digitally enhanced the practice of medicine will be, in the end patients won’t look for platforms, but for outcomes which really matter to them. Value is created by early and correct diagnosis. Value is created by treating as effectively and as individually as possible. That is why we focus on precision medicine.Peter Schardt, CTO Siemens Healthineers
People are key
Hear from our R&D team what motivates them to drive innovation around AI
Collaboration is key
Our R&D wouldn’t be possible without our partners and approximately 4,400 clinical collaborations worldwide. We all share one belief: We’re driving innovations that help people live healthier and longer.
Global infrastructures like the Innovation Think Tank are crucial to drive innovation in a complex and diverse healthcare domain across various regions. It is the right place where ideas, technology, and clinical expertise can meet, be exchanged, and eventually merge. The collaboration with top medical institutions around the world allows us to develop a clear picture for clinical indications and their need for innovative solutions.Peter Schardt, CTO Siemens Healthineers
AdvaMedDX, “A Policy Primer on Diagnostics”, June 2011, p. 3.